🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07718282
Active, not recruiting Not applicable

Acute Effects of Oculomotor Exercises on Posturography and Gait Analysis Parameters in Regular Exercisers

NCT07718282 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-09-02
Last updated
2026-07-21

Condition(s) studied

Postural BalanceGait AnalysisOculomotor SystemExercise

Investigational drug(s) / intervention(s)

Oculomotor Exercise Program

Oculomotor Exercise Program: The intervention consists of a single-session oculomotor exercise program including extraocular eye movement exercises, vestibulo-ocular and cervico-ocular gaze stabilization exercises, and accommodation exercises. During extraocular eye movement exercises, participants will follow a visual target with eye movements while keeping the head stable. During gaze stabilization exercises, participants will maintain visual fixation on a target while performing controlled head movements and walking steps. During accommodation exercises, participants will alternate visual focus between a near target and a distant target. Exercises will be performed at different speeds within the same session.

Study summary

This study aims to investigate the acute effects of a single-session oculomotor exercise program on static posturography and gait analysis parameters in healthy individuals who exercise regularly. Postural control and gait are complex sensorimotor functions that depend on the integration of visual, vestibular, somatosensory, and motor systems. Eye movements and gaze stabilization may contribute to postural orientation and locomotor control by influencing visual-vestibular integration, head-eye coordination, and sensorimotor adaptation. However, the immediate effects of short-duration oculomotor exercise programs on postural sway and gait-related parameters in regular exercisers have not been fully clarified.

This study is designed as a single-group, within-session, pre-post interventional study. Participants will undergo baseline assessments, complete a single session of oculomotor exercises, and then be reassessed after the intervention in the same testing session. The study population will consist of healthy adults who exercise regularly and meet the predefined eligibility criteria. Individuals with musculoskeletal injury, neurological or vestibular disorders, visual conditions that may affect balance or eye movement performance, or any condition limiting participation in the testing procedures will be excluded.

Static posturography will be performed using the HUR SmartBalance BTG4 system to evaluate postural sway under different sensory conditions. Measurements will be obtained during quiet standing with eyes open on a firm surface, eyes closed on a firm surface, eyes open on a foam surface, and eyes closed on a foam surface. The main posturography variables will include sway area, trace length, sway velocity, lateral sway, and anterior-posterior sway.

Gait analysis will be performed before and after the intervention using the DIERS Pedogait system. Spatiotemporal, phase-related, and center-of-pressure-based gait parameters will be recorded. These parameters may include step length, stride length, step time, stride time, track width, cadence, stance phase, swing phase, double support, pre-swing, and center-of-pressure-related gait variables.

The oculomotor exercise program will include three main components: extraocular eye movement exercises, vestibulo-ocular and cervico-ocular gaze stabilization exercises, and accommodation exercises. During extraocular eye movement exercises, participants will be asked to follow a visual target with eye movements while keeping the head stable. During gaze stabilization exercises, participants will maintain visual fixation on a target while performing controlled head movements and walking steps. During accommodation exercises, participants will alternate focus between a near target and a distant target. The exercises will be performed at different speeds to stimulate oculomotor control, gaze stabilization, and visual focusing mechanisms.

The primary outcome of the study is the change in sway area from baseline to the post-intervention assessment. Secondary outcomes include changes in other static posturography parameters and gait analysis variables. By evaluating both postural sway and gait-related outcomes, this study aims to provide preliminary evidence on whether a short oculomotor exercise session may produce immediate changes in postural control and walking characteristics in regular exercisers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy adults aged 18 to 50 years * Regular participation in exercise * Ability to walk independently without an assistive device * Ability to understand and follow the study procedures * Ability to complete the oculomotor exercise program, static posturography assessment, and gait analysis * Provision of written informed consent Exclusion Criteria: * Acute musculoskeletal injury or pain that could affect balance, gait, or exercise performance * Neurological disease that could affect balance, gait, or oculomotor control * Vestibular disorder or current symptoms of dizziness or vertigo * Visual or ocular disorder that could affect visual fixation, eye movements, or balance assessment * Use of medication that could affect balance, coordination, alertness, or gait * Inability to walk independently * Inability to complete the oculomotor exercise intervention or assessment procedures * Any medical condition considered by the investigator to interfere with safe participation or the validity of the assessments

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ege University Faculty of Medicine, Department of Sports Medicine Izmir Bornova

More Ege University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07718282 on ClinicalTrials.gov ↗ ← All trials in Turkey